Current vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2 variants

Scientists at La Jolla Institute for Immunology (LJI) have found that four COVID-19 vaccines (Pfizer-BioNTech, Moderna, J&J/Janssen, and Novavax) prompt the body to make effective, long-lasting T cells against SARS-CoV-2.

Related Keywords

Shane Crotty ,Alba Grifoni ,Camila Coelho ,Alessandro Sette ,Alison Tarke ,Emily Henderson ,Pfizer ,Sette Lab ,Crotty Lab ,Scientists At La Jolla Institute For Immunology ,Crotty Labs ,Omicron ,Antibodies ,D4 ,Fell ,Covid 19 ,Immune Response ,Immune System ,Immunity ,Mmunology ,Mh ,Research ,Cars ,Ars Cov 2 ,Vaccine ,Virus ,